MuCell Extrusion grants rights to Trexel to extend process to EBM

MuCell Extrusion has granted US-based MuCell foaming injection moulding technology maker Trexel rights to offer MuCell technology to the extrusion blow moulding (EBM) market. Trexel has long offered solutions to applications in automotive blow moulding, but until now has been restricted from the EBM market beyond automotive per a non-competition agreement that was part of Trexel’s 2008 sale of its extrusion business to Zotefoams, the parent company of MuCell Extrusion.   

“As Trexel has sharpened its focus on injection moulding packaging applications in recent years, we have seen a pull from the market to offer our MuCell solutions to blow moulded products, leading us to pursue this agreement with MuCell Extrusion,” explains Trexel CEO, Brian Bechard.  

“We are delighted to come to this agreement for Trexel Inc to offer a wider range of solutions to extrusion blow moulding as MuCell Extrusion refocuses on applications for extruded sheet and film,” commented David Stirling, Group CEO of Zotefoams plc.

The MuCell technology provides design flexibility and cost savings opportunities by allowing plastic part design with material wall thickness optimised for functionality and not for the injection moulding process. The combination of density reduction and design for functionality often results in material and weight savings of more than 20%. The numerous cost and processing advantages have led to rapid global deployment of the MuCell process in automotive, consumer electronics, medical, packaging and consumer goods applications.

Process deployment as well as equipment is supported by teams of engineers through Trexel subsidiaries in North America, Europe, and Asia. 

Trexel extended its product offering with the TecoCell system, a chemical foaming technology that provides uniform microcellular structure to injection-moulded parts.

Subscribe to Get the Latest Updates from IMA  Please click here